Affinity: Home blood count monitoring for personalised delivery of cancer therapy

“50%的人预计会在生命中的某个时候患上癌症。即使有了新的治疗方法，许多患者也会在治疗中经历不必要的副作用，这些副作用可能从轻微的心理问题到危及生命的感染。由于癌症患者在医疗机构外花费了大量时间，因此很难识别可能导致此类并发症的早期变化。本项目应是新的家庭监测技术开发的最后阶段，该技术可减少患者不必要的医院就诊，改善副作用的管理，提高生活质量并降低发生危及生命的不良事件的可能性。该平台将允许全身癌症治疗的接受者在家中监测他们的血细胞计数和症状，同时通过与护理提供者直接集成的实时连接与他们的护士和医生共享这些信息。早期的开发工作已经与患者、护理人员、护士和临床医生一起进行，使用以人为本的设计过程，以确保该技术易于使用，并为接受全身癌症治疗的人解决真正的问题。该项目汇集了英国两家领先的医院信托基金，即皇家马斯登NHS基金会信托基金和克里斯蒂NHS基金会信托基金，以及曼彻斯特大学，帝国理工学院健康合作伙伴，Entia和iQ Healthtech，以确保这项创新能够在医疗保健领域迅速采用。"

"50% of people are expected to get cancer at some point in their life. Even with new therapies, many patients will experience unwanted side effects from their treatment that may range from minor psychological issues through to life threatening infections. With cancer patients spending a significant amount of time outside of healthcare facilities, it becomes hard to identify early changes that may lead to such complications. This project shall be the final stage of development for a new home monitoring technology that can reduce unnecessary hospital visits for patients, improve the management of side effects, enhance quality of life and reduce the likelihood of life-threatening adverse events occurring. This platform will operate by allowing recipients of systemic cancer therapy to monitor their blood counts and symptoms within their home whilst sharing that information with their nurses and doctors through a real-time connection that is integrated directly with their care provider. Earlier development work has been undertaken with patients, carers, nurses and clinicians using human centered design processes to ensure that the technology is easy to use and solves genuine problems for people receiving systemic cancer therapy. This project brings together two of the UK's leading hospital trusts, The Royal Marsden NHS Foundation Trust and The Christie NHS Foundation Trust alongside The University of Manchester, Imperial College Health Partners, Entia and iQ Healthtech to ensure this innovation can be rapidly adopted across healthcare."